CORBF (Global Cord Blood) Current Accrued Expense: $19.6 Mil (As of Mar. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CORBF Global Cord Blood Corp CORBF
12 GF Score
Price $0.95
View Full Analysis

What is Global Cord Blood Current Accrued Expense?

Global Cord Blood CORBF 12 Current Accrued Expense is $19.6 Mil as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

Global Cord Blood's Current Accrued Expense for the quarter that ended in Mar. 2022 was $19.6 Mil.

Global Cord Blood's quarterly Current Accrued Expense declined from Sep. 2021 ($23.8 Mil) to Dec. 2021 ($22.7 Mil) and declined from Dec. 2021 ($22.7 Mil) to Mar. 2022 ($19.6 Mil).

Global Cord Blood's annual Current Accrued Expense increased from Mar. 2020 ($13.1 Mil) to Mar. 2021 ($17.3 Mil) and increased from Mar. 2021 ($17.3 Mil) to Mar. 2022 ($19.6 Mil).

Global Cord Blood Current Accrued Expense Related Terms

Global Cord Blood Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood Current Accrued Expense Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.79 8.77 13.12 17.26 19.59

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.26 22.43 23.83 22.71 19.59
CORBF
12GF Score
Global Cord Blood Corp CORBF
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Cord Blood Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $19.6 Mil mean?
Global Cord Blood (CORBF) has a Current Accrued Expense of $19.6 Mil as of Mar. 2022. Current Accrued Expense records the total amount of accrued expenses. View historical data on Global Cord Blood and its competitors.
Is Global Cord Blood's Current Accrued Expense too high?
Global Cord Blood's current Current Accrued Expense is $19.6 Mil. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's Current Accrued Expense compare to PRE and LMDX?
Global Cord Blood's Current Accrued Expense of $19.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Diagnostics & Research company?
A good Current Accrued Expense depends on the Medical Diagnostics & Research industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Global Cord Blood and its competitors. Global Cord Blood's current Current Accrued Expense is $19.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current Current Accrued Expense of $19.6 Mil. The current Current Accrued Expense is $19.6 Mil. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current Current Accrued Expense is $19.6 Mil as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score

Get the complete analysis for CORBF

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price